Cargando…

Generation of human ER chaperone BiP in yeast Saccharomyces cerevisiae

BACKGROUND: Human BiP is traditionally regarded as a major endoplasmic reticulum (ER) chaperone performing a number of well-described functions in the ER. In recent years it was well established that this molecule can also be located in other cell organelles and compartments, on the cell surface or...

Descripción completa

Detalles Bibliográficos
Autores principales: Čiplys, Evaldas, Aučynaitė, Agota, Slibinskas, Rimantas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926315/
https://www.ncbi.nlm.nih.gov/pubmed/24512104
http://dx.doi.org/10.1186/1475-2859-13-22
_version_ 1782303958098771968
author Čiplys, Evaldas
Aučynaitė, Agota
Slibinskas, Rimantas
author_facet Čiplys, Evaldas
Aučynaitė, Agota
Slibinskas, Rimantas
author_sort Čiplys, Evaldas
collection PubMed
description BACKGROUND: Human BiP is traditionally regarded as a major endoplasmic reticulum (ER) chaperone performing a number of well-described functions in the ER. In recent years it was well established that this molecule can also be located in other cell organelles and compartments, on the cell surface or be secreted. Also novel functions were assigned to this protein. Importantly, BiP protein appears to be involved in cancer and rheumatoid arthritis progression, autoimmune inflammation and tissue damage, and thus could potentially be used for therapeutic purposes. In addition, a growing body of evidence indicates BiP as a new therapeutic target for the treatment of neurodegenerative diseases. Increasing importance of this protein and its involvement in critical human diseases demands new source of high quality native recombinant human BiP for further studies and potential application. Here we introduce yeast Saccharomyces cerevisiae as a host for the generation of human BiP protein. RESULTS: Expression of a full-length human BiP precursor in S. cerevisiae resulted in a high-level secretion of mature recombinant protein into the culture medium. The newly discovered ability of the yeast cells to recognize, correctly process the native signal sequence of human BiP and secrete this protein into the growth media allowed simple one-step purification of highly pure recombinant BiP protein with yields reaching 10 mg/L. Data presented in this study shows that secreted recombinant human BiP possesses native amino acid sequence and structural integrity, is biologically active and without yeast-derived modifications. Strikingly, ATPase activity of yeast-derived human BiP protein exceeded the activity of E. coli-derived recombinant human BiP by a 3-fold. CONCLUSIONS: S. cerevisiae is able to correctly process and secrete human BiP protein. Consequently, resulting recombinant BiP protein corresponds accurately to native analogue. The ability to produce large quantities of native recombinant human BiP in yeast expression system should accelerate the analysis and application of this important protein.
format Online
Article
Text
id pubmed-3926315
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39263152014-02-18 Generation of human ER chaperone BiP in yeast Saccharomyces cerevisiae Čiplys, Evaldas Aučynaitė, Agota Slibinskas, Rimantas Microb Cell Fact Research BACKGROUND: Human BiP is traditionally regarded as a major endoplasmic reticulum (ER) chaperone performing a number of well-described functions in the ER. In recent years it was well established that this molecule can also be located in other cell organelles and compartments, on the cell surface or be secreted. Also novel functions were assigned to this protein. Importantly, BiP protein appears to be involved in cancer and rheumatoid arthritis progression, autoimmune inflammation and tissue damage, and thus could potentially be used for therapeutic purposes. In addition, a growing body of evidence indicates BiP as a new therapeutic target for the treatment of neurodegenerative diseases. Increasing importance of this protein and its involvement in critical human diseases demands new source of high quality native recombinant human BiP for further studies and potential application. Here we introduce yeast Saccharomyces cerevisiae as a host for the generation of human BiP protein. RESULTS: Expression of a full-length human BiP precursor in S. cerevisiae resulted in a high-level secretion of mature recombinant protein into the culture medium. The newly discovered ability of the yeast cells to recognize, correctly process the native signal sequence of human BiP and secrete this protein into the growth media allowed simple one-step purification of highly pure recombinant BiP protein with yields reaching 10 mg/L. Data presented in this study shows that secreted recombinant human BiP possesses native amino acid sequence and structural integrity, is biologically active and without yeast-derived modifications. Strikingly, ATPase activity of yeast-derived human BiP protein exceeded the activity of E. coli-derived recombinant human BiP by a 3-fold. CONCLUSIONS: S. cerevisiae is able to correctly process and secrete human BiP protein. Consequently, resulting recombinant BiP protein corresponds accurately to native analogue. The ability to produce large quantities of native recombinant human BiP in yeast expression system should accelerate the analysis and application of this important protein. BioMed Central 2014-02-11 /pmc/articles/PMC3926315/ /pubmed/24512104 http://dx.doi.org/10.1186/1475-2859-13-22 Text en Copyright © 2014 Čiplys et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Čiplys, Evaldas
Aučynaitė, Agota
Slibinskas, Rimantas
Generation of human ER chaperone BiP in yeast Saccharomyces cerevisiae
title Generation of human ER chaperone BiP in yeast Saccharomyces cerevisiae
title_full Generation of human ER chaperone BiP in yeast Saccharomyces cerevisiae
title_fullStr Generation of human ER chaperone BiP in yeast Saccharomyces cerevisiae
title_full_unstemmed Generation of human ER chaperone BiP in yeast Saccharomyces cerevisiae
title_short Generation of human ER chaperone BiP in yeast Saccharomyces cerevisiae
title_sort generation of human er chaperone bip in yeast saccharomyces cerevisiae
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926315/
https://www.ncbi.nlm.nih.gov/pubmed/24512104
http://dx.doi.org/10.1186/1475-2859-13-22
work_keys_str_mv AT ciplysevaldas generationofhumanerchaperonebipinyeastsaccharomycescerevisiae
AT aucynaiteagota generationofhumanerchaperonebipinyeastsaccharomycescerevisiae
AT slibinskasrimantas generationofhumanerchaperonebipinyeastsaccharomycescerevisiae